Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€128.00
06.09.20
06.09.20
€125.00
04.11.21
04.11.21
-3.25%
06.11.20
06.11.20
Future proof or reliable business model
Higher risks for its business
Risky Investment
Verastem Inc.
Start price
Target price
Perf. (%)
€11.94
06.09.20
06.09.20
€24.00
28.09.20
28.09.20
7.41%
28.09.20
28.09.20
Could be very worthwhile Investment >20% year
Fair valuation
Increased challenges to pay loans and raise capital
Risky balance sheet
Novavax Inc.
Start price
Target price
Perf. (%)
€80.99
05.09.20
05.09.20
-
04.11.21
04.11.21
74.71%
03.06.21
03.06.21
Could be very worthwhile Investment >20% year
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€8.70
03.09.20
03.09.20
-
28.10.20
28.10.20
-0.69%
28.10.20
28.10.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.19
03.09.20
03.09.20
-
03.09.20
03.09.20
-
03.09.20
03.09.20
High risks for its business
PerkinElmer Inc.
Start price
Target price
Perf. (%)
€104.00
03.09.20
03.09.20
-
04.11.21
04.11.21
9.62%
05.11.20
05.11.20
Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Grifols S.A.
Start price
Target price
Perf. (%)
€22.77
01.09.20
01.09.20
€30.00
04.11.21
04.11.21
-18.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Uniqure B.V.
Start price
Target price
Perf. (%)
€32.45
29.08.20
29.08.20
€40.00
04.11.21
04.11.21
-7.18%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Stratec SE
Start price
Target price
Perf. (%)
€103.60
29.08.20
29.08.20
€120.00
31.08.20
31.08.20
-3.09%
31.08.20
31.08.20
Risky Investment
Stratec SE
Start price
Target price
Perf. (%)
€105.60
28.08.20
28.08.20
€95.00
04.11.21
04.11.21
5.30%
17.06.21
17.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Very low/no dividend yield expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.32
26.08.20
26.08.20
€50.00
08.10.20
08.10.20
-2.68%
08.10.20
08.10.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Verastem Inc.
Start price
Target price
Perf. (%)
€13.13
25.08.20
25.08.20
€25.20
04.11.21
04.11.21
120.37%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€145.00
25.08.20
25.08.20
-
04.11.21
04.11.21
-32.43%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
25.08.20
25.08.20
€25.62
03.09.20
03.09.20
-2.45%
03.09.20
03.09.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Amgen Inc.
Start price
Target price
Perf. (%)
€207.40
25.08.20
25.08.20
€225.00
21.09.20
21.09.20
-1.23%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Seres Therapeutics Inc
Start price
Target price
Perf. (%)
€21.00
23.08.20
23.08.20
€12.00
04.11.21
04.11.21
-22.14%
17.06.21
17.06.21
Probably not worthwhile Investment
Veracyte Inc.
Start price
Target price
Perf. (%)
€30.20
23.08.20
23.08.20
€45.00
04.11.21
04.11.21
49.01%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Kazia Therapeutics ADR
Start price
Target price
Perf. (%)
€6.50
22.08.20
22.08.20
-
04.11.21
04.11.21
36.15%
17.06.21
17.06.21
Probably not worthwhile Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.65
22.08.20
22.08.20
-
03.09.20
03.09.20
-11.28%
03.09.20
03.09.20
High risks for its business
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€16.70
22.08.20
22.08.20
-
04.11.21
04.11.21
-2.40%
03.06.21
03.06.21
Could be very worthwhile Investment >20% year
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€14.64
22.08.20
22.08.20
-
03.09.20
03.09.20
-40.57%
03.09.20
03.09.20
Could be very worthwhile Investment >20% year